Bariatric Times - September 2008 - (Page 25)

Bariatric Times • September 2008 Surgical Perspective 25 bypass reversal: effect on renal function, metabolic parameters and stone formation. J Urol. 2005;174:1844–6. Halverson JD, Wise L, Wazna MF, et al. Jejunoileal bypass for morbid obesity. A critical appraisal. Am J Med. 1978;64:461–75. Hanni CL, Pool LR, Dean RE, et al. Treatment of jejunoileal bypass failure by anastomosis and gastroplasty in a single-stage procedure. Review of 47 cases. Am Surg. 1984;50:354–7. Dean J. Long-term outcome of reversal of small intestine bypass operations. Am J Surg. 1990;159:118–23. Economou TP, Cullen JJ, Mason EE, et al. Reversal of small intestinal bypass operations and concomitant vertical banded gastroplasty: longterm outcome. J Am Coll Surg. 1995;181:160–4. van Gemert WG, van Wersch MM, Greve JWM, et al. Revisional surgery after failed vertical banded gastroplasty or conversion to gastric bypass. Obes Surg. 1998;8:21–8. Behrns KE, Smith CD, Kelly KA, et al. Repoerative bariatric surgery. Lessons learned to improve patient selection and results. Ann Surg. 1993;218:646–53. Jones KB. Revisional bariatric surgery – safe and effective. Obes Surg. 2001;11:183–9. Gagner M, Gentileschi P, de Csepel J, et al. Laparoscopic reoperative Bariatric surgery: experience from 27 consecutive patients. Obes Surg. 2002;12:254–60. Moon-Han S, Won-Woo K, Oh JH. Results of laparoscopic sleeve gastrectomy at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14:492–7. Catheline JM, Cohen R, Khochtali I, et al. Treatment of super super morbid obesity by sleeve gastrectomy. Presse Med. 2006;35:383–7. Marceau P, Biron S, Bourque RA, et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3:29–35. Hess DS, Hess DW. Biliopancreatic diversion with duodenal switch. Obes Surg. 1998;8:267–82. Baltasar A, Serra C, Pérez N, et al. Laparoscopic sleeve gastrectomy: a multi-purpose Bariatric operation. Obes Surg. 2005;15:1124–8. Langer FB, Reza Honda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9. Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg. 2006;16:554–9. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI>50). Obes Surg. 2005;15:612–7. reversal of their bariatric procedures, these patients require constant medical, nutritional, and psychological follow-up. This is the first report of a JIB reversed to SG, resulting in successful weight loss. Although SG is relatively new to the bariatric surgery arsenal, it has been proven to be a safe and efficient weight loss procedure. Long-term results, however, have yet to be determined. In the meantime, SG is an attractive alternative in JIB patients who are not eligible for gastric bypass because of their malabsorptive-induced metabolic complications. 28. 29. 30. 31. 32. 33. 34. REFERENCES 1. 2. Payne JH, DeWind LT. Surgical treatment of obesity. Am J Surg. 1969;118:141–7. Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejunoileal bypass; the continuing potential need for surgical reversal. Arch Surg. 1995;130:318-25. Livingston EH. Complications of bariatric surgery. Surg Clin N Am. 2005;85:853–68. Buckwalter JA, Herbst CA Jr. Reversal of jejunoileal bypass. Surg Gynecol Obstet. 1984;159:348–52. Anderson PE, Pilkington TRE, Gazet JC. Reversal of jejunileal bypass in patients with morbid obesity. Br J Surg. 1994;81:1015–7. Våge V, Solhaug JH, Berstad A, et al. Jejunoileal bypass in the treatment of morbid obesity: a 25year follow-up study of 36 patients. Obes Surg. 2002;12:312–8. Baddeley RM. Results of jejuno-ileostomy for gross refractory obesity. Br J Surg. 1976;63:801–6. Hallberg D. Surgical treatment of obesity. Prog Surg. 1975;14:46–83. Garcia-Diaz S, Garcia-Fernandez S. Medical and surgical indications for treatment of morbid obesity. World J Surg. 1981;5:795–9. Kremen AT, Linner JH, Nelson CH. Experimental evaluation of nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140:439–48. Leger L, Moullé P, Chiche B, et al. Courts-circuit jejuno-ileaux dans le traitment de l’obesite. 16 cas personnels. J Chir. 1977;113:229–48. Sherman CD Jr., May AG, Nye W, et al. Clinical and metabolic studies following bowel bypassing for obesity. Ann NY Acad Sci. 1965;131:614–22. Salmon PA: The results of small intestinal bypass operations for the treatment of obesity. Surg Ginecol Obst. 1971;132:965–79. Scott HW Jr., Sandstead HH, Brill AB, et al. Experience with a new technique of intestinal bypass in the treatment of morbid obesity. Ann Surg. 1971;174:560–72. Deitel M. Delayed sequelae of jejunoileal bypass. In: Deitel M, ed. Update: Surgery for the Morbidly Obese Patient. Toronto, Canada: Mothersill Printing Inc. 2000;105–111. Jewell R, Hemrock AS, Hardin CA. Complications of jejunoileal bypass for morbid obesity. Arch Surg. 1975;110:1039–42. Lowell JA, Shenoy S, Ghalib R, et al. Liver transplantation after jejunoileal bypass for morbid obesity. J Am Coll Surg. 1997;185:123–7. Markowitz JS, Seu P, Goss JA, et al. Liver transplantation for decompensated cirrhosis after jejunoileal bypass: a strategy for management. Transplantation. 1998;65:570–2. Balsiger BM, Murr MM, Poggio JL, et al. Surgery for weight control in patients with morbid obesity. Med Clin North Am. 2000;84:477–89. Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, et al. A controlled study of peripheral neuropathy after bariatric surgery. Neurology. 2004;63:1462–70. Mole DR, Tomson CRV, Mortensen N, et al. Renal complications of jejuno-ileal byass for obesity. Q J Med. 2001;94:69–77. Drenick EJ, Ament ME, Finegold SM, et al. Bypass enteropathy. Intestinal and systemic manifestations following small-bowel bypass. JAMA. 1976;236:269–72. DeMaria EJ, Jamal MK. Surgical options for obesity. Gastroenterol Clin N Am. 2005;34:127–42. Buckwalter JA, Herbst CA Jr. Reversal of jejunoileal bypass. Surg Gynecol Obstet. 1984;159:348–52. Anderson PE, Pilkington TRE, Gazet JC. Reversal of jejunileal bypass in patients with morbid obesity. Br J Surg. 1994;81:1015–7. Våge V, Solhaug JH, Berstad A, et al. Jejunoileal bypass in the treatment of morbid obesity: a 25year follow-up study of 36 patients. Obes Surg. 2002;12:312–8. Dhar NB, Grundfest S, Jones JS, et al. Jejunoileal 35. 36. 3. 4. 37. 5. 38. 6. 39. 40. 41. 7. 8. 9. 42. 10. 43. 11. 12. 44. 13. 14. 15. 16. 17. ADDRESS FOR CORRESPONDENCE: Samuel Szomstein, MD, FACS, Associate Director, Bariatric Institute and Section of Minimally Invasive Surgery, Department of General and Vascular Surgery, Cleveland Clinic 2950 Cleveland Clinic Boulevard, Weston, Florida, 33331; Phone: (954) 659-5239; E-mail: sszomsts@ccf.org. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. http://www.robard.com

Table of Contents Feed for the Digital Edition of Bariatric Times - September 2008

Bariatric Times - September 2008 Emerging Technologies Case Report Sleeve Gastrectomy after a Jejunoileal Bypass Reversal Editorial Message Contents Editorial Board Walk from Obesity The Latest on Nutrition and Hair Loss in the Bariatric Patient Consultant’s Corner Journal Watch Calendar of Events Advertiser Index

Bariatric Times - September 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.